Biogaia

Biogaia FCF/Debt

The Free Cash Flow to Debt Ratio of Biogaia (BIOG B.ST) as of Nov 16, 2026 is 4,390.83 %. In the previous year, Free Cash Flow to Debt Ratio was 5,057.25 % — a change of -13.18% (lower).

FCF/Debt

4,390.83 %

YoY

-13.18%

Last updated:

Free Cash Flow to Debt Ratio of Biogaia is 2025 4,390.83 % . Free Cash Flow to Debt Ratio of Biogaia was 2024 5,057.25 % . It decreases by -13.18% lower compared to the previous year.

The Biogaia FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2018
-682.71 SEK
Jan 1, 2019
416.12 SEK
Jan 1, 2020
693.18 SEK
Jan 1, 2021
2,072.08 SEK
Jan 1, 2022
1,879.89 SEK
Jan 1, 2023
4,286.94 SEK
Jan 1, 2024
5,057.25 SEK
Jan 1, 2025
4,390.83 SEK
The Biogaia FCF/Debt history
YEARFCF/DebtYoY
4,390.83 %-13.18%
5,057.25 %+17.97%
4,286.94 %+128.04%
1,879.89 %-9.28%
2,072.08 %+198.92%
693.18 %+66.58%
416.12 %-160.95%
-682.71 %+27.66%
-534.79 %-18.09%
-652.86 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biogaia Stock analysis

What does Biogaia do? BioGaia AB generates revenue through its probiotic product segments, primarily featuring Limosilactobacillus reuteri strains. The Paediatrics segment sells drops, gut health tablets, oral rehydration solutions, and cultures for licensee products. The Adult Health segment offers gut health tablets, oral health lozenges, and cultures integrated into dairy products by licensees. The Other segment includes royalties from development projects and revenue from CapAble's packaging solutions. Products are marketed globally to consumers seeking health benefits from probiotics, with licensees distributing branded items under agreements. The company targets health-conscious consumers through direct sales and licensed partnerships. Paediatrics products focus on infant and child health, while Adult Health products address digestive and oral wellness. CapAble, a subsidiary, contributes through packaging solutions, and royalties from development projects provide additional income streams. All segments operate under BioGaia's brand, leveraging documented health benefits of their probiotic strains. Biogaia is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biogaia stock

Free Cash Flow to Debt Ratio of Biogaia is 4,390.83 % in 2025.

Free Cash Flow to Debt Ratio of Biogaia changed from 5,057.25 % to 4,390.83 %, representing a -13.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Biogaia since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Biogaia with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Biogaia

All Key Metrics — Biogaia